Profile data is unavailable for this security.
About the company
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
- Revenue in USD (TTM)49.94bn
- Net income in USD11.76bn
- Incorporated1996
- Employees76.06k
- LocationNovartis AGLichtstrasse 35BASEL 4056SwitzerlandCHE
- Phone+41 613241111
- Fax+41 613247826
- Websitehttps://www.novartis.com/
More ▼
Mergers & acquisitions
Acquired company | NOVN:SWX since announced | Transaction value |
---|---|---|
Mariana Oncology Inc | 2.47% | 1.75bn |
IFM Due Inc | 4.18% | 835.00m |
Cytokinetics Inc | 0.93% | -- |
Calypso Biotech BV | 0.93% | 425.00m |
SanReno Therapeutics | 1.57% | -- |
Data delayed at least 15 minutes, as of Nov 21 2024 12:50 GMT.